CUE HEALTH INC (HLTH) Stock Analyst Earnings Estimates
NASDAQ:HLTH - Nasdaq - US2297901009 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 618.1M 2,587.39% | 483.5M -21.78% | 70.936M -85.33% | 58.123M -18.06% | 111.99M 92.68% | 211.49M 88.85% | 387.03M 83.00% | |
| EBITDA YoY % growth | 222.71M 673.70% | -158.76M -171.29% | -240.436M -51.45% | -150.685M 37.33% | -119.842M 20.47% | -172.937M -44.30% | 36.674M 121.21% | |
| EBIT YoY % growth | 190.2M 521.73% | -203.7M -207.10% | -296.714M -45.66% | -229.875M 22.53% | -183.098M 20.35% | -112.06M 38.80% | -38.2M 65.91% | |
| Operating Margin | 30.77% | -42.13% | -418.28% | -395.50% | -163.50% | -52.99% | -9.87% | |
| EPS YoY % growth | N/A | -1.01 -202.61% | -2.56 -153.47% | -1.12 56.30% | -0.66 40.73% | -0.21 68.46% | -0.28 -31.71% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 38.03% | -0.30 45.60% | -0.26 39.91% | -0.24 75.21% | -0.22 41.59% | -0.19 35.23% | -0.18 30.92% | -0.16 33.57% |
| Revenue Q2Q % growth | 10.305M -58.39% | 9.742M -1.56% | 13.683M -21.71% | 25.662M 36.51% | 26.316M 155.37% | 19.38M 98.93% | 23.868M 74.44% | 32.436M 26.40% |
| EBITDA Q2Q % growth | -27.132M 64.27% | -25.704M 52.73% | -25.5M 4.54% | -26.52M -194.47% | -20.298M 25.19% | -18.36M 28.57% | -15.708M 38.40% | -14.892M 43.85% |
| EBIT Q2Q % growth | -58.615M 33.39% | -55.833M 29.15% | -53.89M 16.71% | -52.846M 19.05% | -48.552M 17.17% | -45.492M 18.52% | -41.82M 22.40% | -40.902M 22.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.96 -357.14% | -0.44 | -0.52 | -120.16% |
| Q3 2023 Q2Q % growth | -0.43 4.44% | -0.46 | 0.03 | 6.32% |
| Q2 2023 Q2Q % growth | -0.55 -48.65% | -0.53 | -0.02 | -4.70% |
| Q1 2023 Q2Q % growth | -0.62 -3,200.00% | -0.62 | 0.00 | -0.06% |
| Q4 2022 Q2Q % growth | -0.21 -195.45% | -0.52 | 0.31 | 59.63% |
| Q3 2022 Q2Q % growth | -0.45 -446.15% | -0.55 | 0.10 | 18.68% |
| Q2 2022 Q2Q % growth | -0.37 | -0.47 | 0.10 | 21.57% |
| Q1 2022 Q2Q % growth | 0.02 | -0.05 | 0.07 | 137.35% |
| Q4 2021 Q2Q % growth | 0.22 | 0.11 | 0.11 | 105.42% |
| Q3 2021 Q2Q % growth | 0.13 | 1.51 | -1.38 | -91.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 18.798M -87.19% | 18.034M | 764K | 4.24% |
| Q3 2023 Q2Q % growth | 17.477M -74.89% | 16.997M | 480K | 2.82% |
| Q2 2023 Q2Q % growth | 9.896M -88.72% | 13.633M | -3.737M | -27.41% |
| Q1 2023 Q2Q % growth | 24.765M -86.20% | 23.479M | 1.286M | 5.48% |
| Q4 2022 Q2Q % growth | 146.8M -23.74% | 48.729M | 98.071M | 201.26% |
| Q3 2022 Q2Q % growth | 69.6M -68.89% | 59.327M | 10.273M | 17.32% |
| Q2 2022 Q2Q % growth | 87.7M -56.57% | 53.96M | 33.74M | 62.53% |
| Q1 2022 Q2Q % growth | 179.4M | 178.65M | 750K | 0.42% |
| Q4 2021 Q2Q % growth | 192.5M 1,347.37% | 189M | 3.5M | 1.85% |
| Q3 2021 Q2Q % growth | 223.7M 4,659.57% | 204.31M | 19.39M | 9.49% |
| Q2 2021 Q2Q % growth | 201.922M 3,971.01% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -46.75% | 0% | -26.54% |
| Revenue | 0% | -65.07% | 0% | -38.23% |